Publications - COG Analytics

In Press

Lounsbury DW, Mitchell SG, Dusek K, Li Z, Kirk AS, Oros M, Hosler C, Schwartz RP, Gryczynski J, Monico LB & Brown BS (in press). Application of System Dynamics Modeling to Inform Implementation of Adolescent SBIRT in Primary Care Settings. Journal of Behavioral Health Services & Research.

2024

2023

Carswell, S.B., Alexander, K., Gryczynski, J., Knowlton, A.R., Abatemarco, D.J., Horodyski, A.M., & Mitchell, M.M. (2023). Mindfulness-based mobile application for African American caregivers. Journal of Technology in Behavioral Science.

Carswell, S.B., Gordon, M.S., Gryczynski, J., Horodyski, A.M., Ferguson, K.N., Maher, K.M., & Vocci, F.J. (2023). The daily progress system – A recovery support tool to improve engagement and retention in outpatient substance use treatment. Journal of Substance Use. DOI: 10.1080/14659891.2023.2261036.

2022

Carswell SB, Gordon MS, Gryczynski J, Taxman FS, Schadegg M, Ferguson KN, Maher KM (2022). Continuing care app for probationers and parolees with substance use disorders. Journal of Drug Education, 51. (1-2), 32-48, DOI 10.1177/00472379221111.

Gryczynski J, Sanchez K, Carswell SB & Schwartz RP (2022). Development, feasibility, and preliminary validation of a Spanish language version of the TAPS Tool for substance use screening in primary care. Addiction Science & Clinical Practice,. 17(S1), 33.

2021

2020

2019

Gordon MS, Vocci FJ, Taxman F, Fishman M, Sharma B, Blue TR, O’Grady KE (2019). A Randomized Controlled Trial of Buprenorphine for Probationers and Parolees: Bridging the Gap into Treatment. Contemporary Clinical Trials. 79:21-27. doi: 10.1016/j.cct.2019.02.009. Epub 2019 Feb 20. PMID: 30797042.

Gryczynski J, Mitchell SG, Schwartz RP, Kelly SM, Dušek K, Monico L, O’Grady KE, Brown BS, Oros M, Hosler C (2019). Disclosure of Adolescent Substance Use in Primary Care: Comparison of Routine Clinical Screening and Anonymous Research Interviews. Journal of Adolescent Health. 64(4):541-543. doi: 10.1016/j.jadohealth.2018.10.009. Epub 2018 Dec 18. PMID: 30578116.

Gryczynski J, Nichols H, Schwartz RP, Mitchell SG, Hill P, Wireman K (2019). Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder. Drug and Alcohol Dependence. 2019 Aug 30; 204:107515. doi: 10.1016/j.drugalcdep.2019.06.017. [Epub ahead of print] PMID: 31525569.

Mitchell, M.M., Mendelson, J. Gryczynski, J., Carswell, S.B., & Schwartz, R.P. (2019). A novel telehealth platform for alcohol use disorder treatment: Preliminary evidence of reductions in drinking. The American Journal of Drug and Alcohol Abuse. DOI: 10.1080/00952990.2019.1658197.

Monico LB, Mitchell SG, Dusek K, Gryczynski J, Schwartz RP, Oros M, Hosler C, O’Grady KE, Brown BS (2019). A Comparison of Screening Practices for Adolescents in Primary Care After Implementation of Screening, Brief Intervention, and Referral to Treatment. Journal of Adolescent Health. Journal of Adolescent Health. 65(1):46-50. doi: 10.1016/j.jadohealth.2018.12.005. Epub 2019 Mar 6. PMID: 30850312.

Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Jaffe JH (2019). Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests. Journal of Substance Abuse Treatment. 97:7-13. doi: 10.1016/j.jsat.2018.11.006. Epub 2018 Nov 19. PMID:30577902.

Schwartz RP, Mitchell MM, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Gordon MS, Jaffe JH (2019). Pharmacotherapy for Opioid Addiction in Community Corrections. International Review of Psychiatry. 2018 Dec 6:1-19. doi: 10.1080/09540261.2018.1524373. [Epub ahead of print] PMID: 30522370.

2018

Carswell SB, Gordon MS, Gryczynski J, and Tangires S (2018). The daily progress system: A proof of concept pilot study of a recovery support technology tool for outpatient substance abuse treatment. The American Journal of Drug and Alcohol Abuse. Published online: 30 May 2018.

Dunlap LJ, Zarkin GA, Orme S, Meinhofer A, Kelly SM, O’Grady KE, Gryczynski J, Mitchell SG, Schwartz RP (2018). Re-engineering methadone-Cost-effectiveness analysis of a patient-centered approach to methadone treatment. Journal of Substance Abuse Treatment. 94:81-90. doi: 10.1016/j.jsat.2018.07.014. Epub 2018 Jul 31. PMID: 30243422.

Gordon MS, Blue TR, Couvillion K, Schwartz RP, O’Grady KE, Fitzgerald TT & Vocci FJ (2018). Impact of Starting Buprenorphine Treatment Prior to vs. After Release from Prison: Arrest Outcomes. Drug and Alcohol Dependence.

Gordon MS, Blue TR, Couvillion K, Schwartz RP, O’Grady KE, Fitzgerald TT, Vocci FJ (2018). Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes. Drug and Alcohol Dependence. 188:232-238. doi: 10.1016/j.drugalcdep.2018.04.010. Epub 2018 May 12. PMID: 29783095.

Gordon MS, Crable EL, Carswell SB, Leopold J, Hodo-Powell J, McKenzie M, and Rich JD (2018). A randomized controlled trial of intensive case management (Project Bridge) for HIV-infected probationers and parolees. AIDS and Behavior. 22(3):1030-1038. doi: 10.1007/s10461-017-2016-y. PMID: 29273946.

Gryczynski J, Carswell SB, (2018). Gender and ethnic differences in primary care patients' response to computerized vs. in-person brief intervention for illicit drug misuse. Journal of Substance Abuse Treatment. 84:50-56. doi: 10.1016/j.jsat.2017.10.009. Epub 2017 Nov 7. PMID: 29195593.

Gryczynski J, Schwartz RP, Fishman MJ, Nordeck CD, Grant J, Nidich S, Rothenberg S, O’Grady KE (2018). Integration of Transcendental Meditation® (TM) into alcohol use disorder (AUD) treatment. Journal of Substance Abuse Treatment. 87:23-30. doi: 10.1016/j.jsat.2018.01.009. Epub 2018 Jan 16. PMID:29471923.

Mitchell SG, Gryczynski J, Schwartz RP (2018). Commentary on "The More Things Change: Buprenorphine/Naloxone Diversion Continues While Treatment is Inaccessible". Journal of Addiction Medicine. 12(6):424-425. doi: 10.1097/ADM.0000000000000437. PMID:30095564.

Mitchell SG, Monico LB, Lertch E, Kelly SM, Gryczynski J, Jaffe J, O’Grady KE, & Schwartz RP (2018). Counseling staff's views of patient-centered methadone treatment: Changing program rules and staff roles. The Journal of Behavioral Health Services and Research. 45(3):506-515. doi: 10.1007/s11414-018-9603-1. PMID: 29536342.

Monico LB, Gryczynski J, Schwartz RP, Jaffe JH, O’Grady KE, & Mitchell SG (2018). Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12-months. The American Journal of Drug and Alcohol Abuse. 44(6):604-610. doi: 10.1080/00952990.2018.1461877. Epub 2018 May 2. PMID: 29718715.

Nordeck CD, Welsh C, Schwartz RP, Mitchell SG, Cohen A, O’Grady KE, Gryczynski J (2018). Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service. Drug and Alcohol Dependence. 186:23-28. doi: 10.1016/j.drugalcdep.2017.12.043. Epub 2018 Mar 2. PMID: 29529456.

Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ (2018). Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry. Addiction. 113(8):1477-1487. doi: 10.1111/add.14199. Epub 2018 Apr 1. PMID: 29493836.

2017

Gordon MS, Carswell SB, Peters EN, Tangires S, Kinlock TW, Vocci FJ, and Restivo L (2017). Avatar assisted therapy: A novel technology-based Intervention to treat substance use disorders. In Pam Lassiter (ed.), Annual Review of Addictions and Offender Counseling: Best Practices III. (p 97 - 114). Eugene, OR: Wipf & Stock Publishers.

Gordon MS, Carswell SB, Schadegg M, Mangen K, Merkel K, Tangires S, Vocci FJ (2017). Avatar-assisted therapy: a proof-of-concept pilot study of a novel technology-based intervention to treat substance use disorders. American Journal of Drug and Alcohol Abuse. 43(5):518-524. doi: 10.1080/00952990.2017.1280816.

Gordon MS, Kinlock TW, Schwartz RP, O’Grady KE, Fitzgerald TT, Vocci FJ (2017). A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release. Drug and Alcohol Dependence. 172:34-42. doi: 10.1016/j.drugalcdep.2016.11.037. Epub 2017 Jan 11. PMID: 28107680.

Gordon MS, Vocci FJ, Fitzgerald TT, O’Grady KE, O’Brien CP (2017). Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment. Contemporary Clinical Trials. 53:130-136. doi: 10.1016/j.cct.2016.12.015. PMID:28011389.

Gryczynski J, McNeely J, Wu LT, Subramaniam GA, Svikis DS, Cathers LA, Sharma G, King J, Jelstrom E, Nordeck CD, Sharma A, Mitchell SG, O’Grady KE, Schwartz RP (2017). Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. Journal of General Internal Medicine. 32(9):990-996. doi: 10.1007/s11606-017-4079-x. Epub 2017 May 26. PMID: 28550609.

Gryczynski J, Nordeck CD, Mitchell SG, Page KR, Johnsen LL, O’Grady KE, Schwartz RP (2017). Pilot Studies Examining Feasibility of Substance Use Disorder Screening and Treatment Linkage at Urban Sexually Transmitted Disease Clinics. Journal of Addiction Medicine. 11(5):350-356. doi: 10.1097/ADM.0000000000000327. PMID: 28590392.

Kelly SM, O’Grady KE, Gryczynski J, Mitchell SG, Kirk A, Schwartz RP (2017). The concurrent validity of the Problem Oriented Screening Instrument for Teenagers (POSIT) substance use/abuse subscale in adolescent patients in an urban federally qualified health center. Substance Abuse. 38(4):382-388. doi: 10.1080/08897077.2017.1351413. Epub 2017 Jul 7. PMID: 28686545.

Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M (2017). Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm. Journal of Addiction Medicine. 11(3):211-216. doi: 10.1097/ADM.0000000000000299. PMID:28252456.

Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2017). Patient‐centered methadone treatment: a randomized clinical trial. Addiction. 112(3):454-64.

Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Jaffe JH (2017). When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest records. Drug and Alcohol Dependence. 180:385-390. doi: 10.1016/j.drugalcdep.2017.08.025. Epub 2017 Sep 14. PMID: 28961545.

Schwartz RP, McNeely J, Wu LT, Sharma G, Wahle A, Cushing C, Nordeck CD, Sharma A, O’Grady KE, Gryczynski J, Mitchell SG, Ali RL, Marsden J, Subramaniam G (2017). Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of Substance Abuse Treatment. 76, 69-76.

Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP (2017). Update on Barriers to Pharmacotherapy for Opioid Use Disorders. Current Psychiatry Reports. 19(6):35. doi: 10.1007/s11920-017-0783-9. Review. PMID: 28526967.

2016

Gordon MS, Carswell SB, Wilson M, Kinlock TW, Restivo LL, McKenzie M, Rich JD, (2016). Factors Associated With Receiving Rapid HIV Testing Among Individuals on Probation or Parole. Journal of Correctional Health Care. 22(4):290-299. PMID: 27742854.

Gryczynski J, O’Grady KE, Mitchell SG, Ondersma SJ, Schwartz RP (2016). Immediate Versus Delayed Computerized Brief Intervention for Illicit Drug Misuse. Journal of Addiction Medicine. 10(5):344-51. doi: 10.1097/ADM.0000000000000248. PMID: 27504925.

Gryczynski J, Schwartz RP, O’Grady KE, Restivo LL, Mitchell SG, Jaffe JH (2016). Understanding patterns of high-cost health care use across different substance user groups. Health Affairs. (Millwood). 35(1):12-9. doi: 10.1377/hlthaff.2015.0618. PMID: 26733696 PMCID: PMC4936480 DOI: 10.1377/hlthaff.2015.0618.

Mitchell SG, Schwartz RP, Kirk AS, Dušek K, Oros M, Hosler C, Gryczynski J, Barbosa C, Dunlap L, Lounsbury D, O’Grady KE, Brown BS (2016). SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers. Journal of Substance Abuse Treatment. 60:81-90. doi:10.1016/j.jsat.2015.06.011. Epub 2015 Jun 26. PMID: 26297321.

Monico LB, Schwartz RP, Gryczynski J, O’Grady KE, Mitchell SG (2016). Two models of integrating buprenorphine treatment and medical staff within formerly "drug-free" outpatient programs. Journal of Psychoactive Drugs. 48(2):101-8. doi: 10.1080/02791072.2015.1130884. PMID: 26940870.

O’Grady KE, Gryczynski J, Mitchell SG, Ondersma SJ, Schwartz RP (2016). Confirmatory factor analysis of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in community health center patients. American Journal on Addictions. 25(4):259-63. doi: 10.1111/ajad.12360. PMID: 27037633.

Ondersma SJ, Gryczynski J, Mitchell SG, O’Grady KE, Schwartz RP (2016). Process evaluation of a technology-delivered screening and brief intervention for substance use in primary care. Internet Interventions. 4(Pt 1):11-16. PMID: 27110494PMCID: PMC4836054. DOI: 10.1016/j.invent.2016.01.004.

Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, Vocci FJ (2016). Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: A randomized clinical trial. Journal of the American Medical Association. 316(3), 282-290.

Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2016). Patient-centered methadone treatment: a randomized clinical trial. Addiction. doi: 10.1111/add.13622. [Epub ahead of print]. PMID: 27661788.

Sharma A, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Schwartz RP (2016). Confirmatory factor analysis of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in community health center patients. Substance Abuse and Rehabilitation. 7:27-40. doi: 10.2147/SAR.S81602. Review. PMID: 27217808. PMCID: PMC4853155 DOI: 10.2147/SAR.S81602.

2015

Barbosa C, Dunlap LJ, Wedehase B, Mitchell SG, Schwartz RP, Dušek K, Kirk AS, Oros M, Hosler C, Gryczynski J, Brown BS (2015). Start-up costs of implementing Screening and Brief Intervention (SBI) for Adolescents (part of Economics of SBI symposium). Addiction Science and Clinical Practice. 10 (Suppl 2), O5.

Gordon MS, Kinlock TW, Schwartz RP, Couvillion KA, Sudec LJ, O’Grady KE, Vocci FJ, Shabazz H (2015). Buprenorphine Treatment for Probationers and Parolees. Substance Abuse. 36(2):217-25. doi: 10.1080/08897077.2014.902787. Epub 2014 Apr 4. PMID: 24701967.

Gordon MS, Kinlock TW, Vocci FJ, Fitzgerald TT, Memisoglu A, Silverman B (2015). A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners. Journal of Substance Abuse Treatment. 59:52-8. doi: 10.1016/j.jsat.2015.07.005. Epub 2015 Jul 18. PMID: 26299956.

Gryczynski J, Kelly SM, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2015). Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients. Addiction. 110(2):240-7. doi: 10.1111/add.12767. Epub 2014 Nov 20. PMID: 25311148.

Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, Ondersma SJ, O’Grady KE, Schwartz RP (2015). A randomized trial of computerized vs. in-person brief intervention for illicit drug use in primary care: outcomes through 12 months. Journal of Substance Abuse Treatment. 50, 3-10. doi: 10.1016/j.jsat.2014.09.002. Epub 2014 Sep 16. PMID: 25282578.

Gryczynski J, Mitchell SG, Jaffe JH, O’Grady KE, Olsen YK, Schwartz RP (2015). Leaving buprenorphine treatment: patients' reasons for cessation of care. Journal of Substance Abuse Treatment. 46(3):356-61. PubMed PMID: 24238714; PubMed Central PMCID: PMC3947058.

Gryczynski J, Mitchell SG, Ondersma SJ, O’Grady KE, Schwartz RP (2015). Potential radiating effects of misusing substances among medical patients receiving brief intervention. Journal of Substance Abuse Treatment. 55:39-44.

Gryczynski J, Nordeck C, Mitchell SG, O’Grady KE, McNeely J, Wu L-T, Schwartz RP (2015). Reference periods in retrospective behavioral self-report: A qualitative investigation. American Journal on Addictions. 24(8): 744-747.

Gryczynski J, Schwartz RP, Mitchell SG, Dzirasa L, Dušek K, O’Grady K, and Cowell A (2015). Preliminary research in preparation for a randomized trial of brief intervention strategies for adolescents in school-based health centers. Addiction Science and Clinical Practice. 10 (Suppl 2), O20. http://doi.org/10.1186/1940-0640-10-S2-O20.

Mitchell SG, Gryczynski J, Schwartz RP, Myers CP, O’Grady KE, Olsen YK, Jaffe JH (2015). Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use. Journal of Psychoactive Drugs. 47(2):149-57.

Mitchell SG, Monico LB, Gryczynski J, O’Grady KE, Schwartz RP (2015). Staff Views of Acceptability and Appropriateness of a Computer-Delivered Brief Intervention for Moderate Drug and Alcohol Use. Journal of Psychoactive Drugs. 47(4):301-7. doi: 10.1080/02791072.2015.1075631. Epub 2015 Sep 16. PMID: 26375411.

Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O’Grady KE, Jaffe JH (2015). Buprenorphine treatment and 12-step meeting attendance: conflicts, compatibilities, and patient outcomes. Journal of Substance Abuse Treatment. 57:89-95. doi: 10.1016/j.jsat.2015.05.005. Epub 2015 May 12. PMID: 25986647.

Monico LB, Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2015). Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention. Journal of Substance Abuse Treatment. 57:57-62. doi: 10.1016/j.jsat.2015.04.010. Epub 2015 May 7. PMID: 25980599.

Peters EN, Harrell PT, Hendricks PS, O’Grady KE, Pickworth WB, Vocci FJ (2015). Electronic cigarettes in adults in outpatient substance use treatment: Awareness, perceptions, use, and reasons for use. American Journal on Addictions. 24(3):233-9.

Schwartz RP, Kelly SM, Gryczynski J, Mitchell SG, O’Grady KE, Jaffe JH (2015). Heroin use, HIV-risk, and criminal behavior in Baltimore: Findings from Clinical Research. Journal of Addictive Diseases. 34(2-3):151-61. doi: 10.1080/10550887.2015.1059222. PMID: 26079104.

Vocci FJ, Schwartz RP, Wilson ME, Gordon MS, Kinlock TW, Fitzgerald TT, O’Grady KE, Jaffe JH (2015). Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners. Drug and Alcohol Dependence. 156:133-8. doi: 10.1016/j.drugalcdep.2015.09.001. Epub 2015 Sep 7. PMID: 26409751.

2014

Carswell SB, Hanlon TE, O’Grady KE, Watts AM (2014). Correlates of risky sexual activity for urban African American youth in an alternative education program. Education and Urban Society. 46(4), 434-449. doi:10.1177/0013124512458119.

Carswell SB, Hanlon TE, Watts A, O’Grady KE (2014). Prevention-related research targeting African American alternative education program students. Education and Treatment of Children. 46(4), 434-449. doi:10.1177/0013124512458119.

Gordon MS, Kinlock TW, Schwartz RP, Fitzgerald TT, O’Grady KE, Vocci FJ (2014). A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry. Drug and Alcohol Dependence. 142, 33-40. doi: 10.1016/j.drugalcdep.2014.05.011. Epub 2014 Jun 2. PMID: 24962326.

Gryczynski J, Schwartz RP, Mitchell SG, O’Grady KE, Ondersma SJ (2014). Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use. Drug and Alcohol Dependence. 141:44-50. doi: 10.1016/j.drugalcdep.2014.05.001. Epub 2014 May 17. PMID: 24932945. PMCID: PMC4080811.

Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. Drug and Alcohol Dependence. 140:213-6. PubMed PMID: 24793367; PubMed Central PMCID: PMC4070874.

Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics. 133(5):819-26. PubMed PMID: 24753528; PubMed Central PMCID: PMC4006430.

Mitchell SG, Gryczynski J, Kelly SM, O’Grady KE, Jaffe JH, Olsen YK, Schwartz RP (2014). Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status. Journal of Drug Issues. 44(1):69-82. PMID:25364037.

Mitchell SG, Kelly SM, Gryczynski J, Myers CP, O’Grady KE, Kirk AS, Schwartz RP (2014). The CRAFFT Cut-Points and DSM-5 Criteria for Alcohol and Other Drugs: A Reevaluation and Reexamination. Substance Abuse. 35(4):376-80. PubMed PMID: 25036144; PubMed Central PMCID: PMC4268117.

Paterson NE, Vocci F, Sevak RJ, Wagreich E, London ED (2014). Dopamine D3 receptors as a therapeutic target for methamphetamine dependence. American Journal of Drug and Alcohol Abuse. 40(1):1-9. PubMed PMID: 24359505.

Peters EN, Hendricks PS, Clark CB, Vocci FJ, Cropsey KL (2014). Association of race and age with treatment attendance and completion among adult marijuana users in community-based substance abuse treatment. Journal of Addiction Medicine. 8(2):143-9. PubMed PMID: 24603621.

Schwartz RP, Alexandre PK, Kelly SM, O’Grady KE, Gryczynski J, Jaffe JH (2014). Interim versus standard methadone treatment: a benefit-cost analysis. Journal of Substance Abuse Treatment. 46(3):306-14. doi: 10.1016/j.jsat.2013.10.003. Epub 2013 Oct 14.PMID:24239030.

Schwartz RP, Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, Ondersma SJ, O’Grady KE (2014). Computerized versus in-person brief intervention for drug misuse: a randomized clinical trial. Addiction. 109(7):1091-8. doi: 10.1111/add.12502. Epub 2014 Mar 10. PMID: 24520906. PMCID: PMC4086904.

2013

Gryczynski J, Jaffe JH, Schwartz RP, Dušek KA, Gugsa N, Monroe CL, O’Grady KE, Olsen YK, Mitchell SG (2013). Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system. American Journal on Addictions. 22(3):285-91.

Gryczynski J, Mitchell SG, Jaffe JH, Kelly SM, Myers CP, O’Grady KE, Olsen YK, Schwartz RP (2013). Retention in methadone and buprenorphine treatment among African Americans. Journal of Substance Abuse Treatment. 45(3):287-92.

Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP (2013). SBIRT for adolescent drug and alcohol use: current status and future directions. Journal of Substance Abuse Treatment. 44 (5), 463-472.

Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2013). A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans. Drug and Alcohol Dependence. 128 (3), 222-229.

Rosenthal RN, Ling W, Casadonte P, Vocci F, Bailey GL, Kampman K, Patkar A, Chavoustie S, Blasey C, Sigmon S, Beebe KL (2013). Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone. Addiction. 108(12):2141-9. doi: 10.1111/add.12315. Epub 2013 Sep 18. PMID: 23919595.

Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. American Journal of Public Health. 103(5):917-22.

Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen YK, Mitchell SG, Jaffe JH (2013). Schwartz et al. respond. American Journal of Public Health. 2013 103(8):e2-3..Epub 2013 Jun 13.

Serpelloni G, Gomma M, Genetti B, Zermiani M, Rimondo C, Mollica R, Gryczynski J, O’Grady KE, Schwartz RP (2013). Italy’s electronic health record system for opioid agonist treatment. Journal of Substance Abuse Treatment. 45(2):190-5.

2012

Caldwell D, Gryczynski J (2012). Computerized assessment facilitates disclosure of sensitive HIV risk behaviors among African Americans entering substance abuse treatment. American Journal of Drug and Alcohol Abuse. 38 (4), 365-369.

Gonzales A, Westerberg VS, Peterson TR, Moseley A, Gryczynski J, Mitchell SG, Buff G, Schwartz RP (2012). Implementing a statewide Screening, Brief Intervention, and Referral to Treatment (SBIRT) service in rural health settings: New Mexico SBIRT. Substance Abuse. 33 (2), 114-123. [PMCID: PMC3325793].

Gryczynski J, Kinlock TW, Kelly SM, O’Grady KE, Gordon MS, Schwartz RP (2012). Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime. Substance Abuse. 33 (1), 30-39.

Gryczynski J, Ward BW (2012). Religiosity, heavy alcohol use, and vicarious learning networks among adolescents in the United States. Health Education and Behavior. 39 (3), 341-351.

Mitchell SG, Gryczynski J, Peterson T, Gonzales A, Moseley A, Schwartz RP (2012). Screening, Brief Intervention, and Referral to Treatment (SBIRT) for substance use in a school-based program: Services and outcomes. American Journal on Addictions. 21 S5-S13.

Mitchell SG, Kelly SM, Gryczynski J, Myers CP, Jaffe JH, O’Grady KE, Olson YK, Schwartz RP (2012). African-American patients seeking treatment in the public sector: Characteristics of buprenorphine v. methadone patients. Drug and Alcohol Dependence. 122, 55-60. [PMCID: PMC3251709].

Wiechelt SA, Gryczynski J, Johnson JL, Caldwell D (2012). Historical trauma among urban American Indians: Impact on substance abuse and family cohesion. Journal of Loss and Trauma. 17 (4), 319-336.